Delivery Order SPE2DB25D3012-SPE2DB25FXALP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2024, for the supply of Ondansetron ODT 8 mg tablets (30 count) with a contract value of $17,810.92. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2024, represents a non-competitive set-aside award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $8,059.34 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The award is non-competitive and structured as a firm fixed price delivery order, with an ultimate completion date of May 19, 2025. Performance of this contract will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $25,388.02. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a ceiling value of $1,148.89. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packaging) valued at $2,350.06. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive, non-set-aside delivery order carries a ceiling value of $5,838.82 under a firm fixed price arrangement, with an ultimate completion date of September 10, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $7,814.55. The delivery order utilizes firm fixed pricing with no set-aside designation, indicating competitive award through an open solicitation process. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $4,885.54. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a $11,073.06 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXALPDelivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $184,040.90, reflects a firm fixed-price arrangement with an ultimate completion date of September 25, 2025. The award carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical supply vehicle enables the contractor to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare systems globally. Ondansetron, a commonly prescribed antiemetic medication, is consistent with the contractor's portfolio of pharmaceutical products supplied to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award demonstrates the contractor's continued role as a critical pharmaceutical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $184.0k | 9/24/25 |